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Key Points
• The study by Stojanov et al does not convincingly support the
conclusion that gadobutrol causes higher T1 enhancement
in brain on unenhanced MRI
• The study by Stojanov et al does not rule out confounding
factors
• The study by Stojanov et al has limitations in study design
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We readwith great interest the recent article by Stojanov et al. [1].
In this article, the authors state that B…an increase in SI within
the dentate nucleus and globus pallidus on unenhanced T1W
images in patients with RRMSmay be a consequence of multiple
administrations of gadobutrol. Administration of the same
amount of gadobutrol over a shorter time period causes a great-
er increase in SI within the dentate nucleus and globus pallidus.^
The authors’ findings are new as this is the first time that a
macrocyclic gadolinium-based contrast agent (GBCA) is sug-
gested to be associated with this phenomenon. Prior studies,
such as the 2009 Roccatagliata et al study [2], where the pa-
tients received gadoterate meglumine (Dotarem) and
gadodiamide (Omniscan), reported hyperintensity in dentate
nuclei in patients with secondary progressive MS, which they
attributed to, among other things, the disease and particularly
the severity of the disease process itself, or potentially linked
to the associated iron depositions as demonstrated in tissue
specimens by Craelius et al. [3].
The title and abstract suggest an association between high
signal intensity (SI) and a macrocyclic GBCA, which is less
likely to release free gadolinium. However, the study design
and authors’ data do not rule out a number of potentially
confounding factors that could contribute to any direct asso-
ciation, though some of the limitations have been acknowl-
edged in the author’s discussion. For example:
& Although other causes or the disease process itself has
been proposed as causes for the hyperintensity, this retro-
spective comparison did not include a control group of
patients with no CNS or a non-MS disease.
& The authors specifically acknowledge that they could not
control for or exclude the use of other contrast agents, in-
cluding linear GBCAs. The fact that the baseline values
(before the first gadobutrol dose) show elevated SI raises
the possibility that there may have been either confounding
contrast agent contamination prior to the first contrast-
enhancedMRI that was used as the reference or other causes
such as the previously discussed disease itself or associated
iron depositions, which may play a critical role [3].
& Patients were evaluated in three groups with different inter-
vals of contrast administration. The different intervals be-
tween contrast-enhancedMRImay be indicative of different
disease activity and/or treatment regimens requiring more
frequent follow-up exams. This could introduce a bias if the
disease activity itself is contributing to the hyperintensity.
This might explain why the most prominent effect was in
the groupwith the shortest period of contrast administration.
& The scatter plot (Fig. 3) shows a correlation of 0.263,
which is very low when compared to other similar studies,
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suggesting a potential unknown cause other than the ad-
ministration of gadobutrol [4]. As common practice, a
correlation of 0.50 or more is regarded as moderate and
correlations of 0.75 or above as strong. Additionally, the
number of administrations showed a statistically signifi-
cant correlation to the increase in SI, but the total amount
of contrast did not. This creates unanswered questions
because the number of administrations and total amount
of contrast are highly correlated.
& Any visible changes in SI are not specifically mentioned
and are difficult to appreciate even on the selected images
provided in the paper, but only SI measurements are re-
ported. Prior publications onMS have explored the impor-
tance of the region size and location on the quantitative
measures, but this study does not specify any control to
ensure the regions on the first and last scans were similar
in size and location. The regions-of-interest may have
been determined anatomically by consensus, rather than
based on observable areas of signal increase.
In summary, there are concerns that limitations in the
study design do not support any conclusion regarding the
role of repeated administrations of gadolinium-based con-
trast agents in general or a specific contrast agent in this
particular patient group.
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